The collaborative transplant study registry

Chronic lung allograft dysfunction phenotypes and treatment

“…BOS was defined as a persistent, obstructive decrease in forced expiratory volume in 1 second (FEV1) with at least 20% compared to the mean of the two best post-transplant values, in the absence of other identifiable causes such as acute rejection, infection, suture problems… Further stratification was made according to the relative decrease in FEV 1 and consequently a grading system was introduced being BOS1 (FEV 1 66-80% of best), BOS2 (FEV 50-65% of best) and BOS3 (<50% of best). BOS was thought to be a functional reflection of obliterative bronchiolitis (OB).…”

“…Although survival has improved spectacularly following lung transplantation, it still limbs behind that after other solid organ transplantations (1). Although improvement in surgical techniques and clinical expertise led to an improved in initial survival, long-term overall outcome remains poor.…”

Transfusion medicine and solid organ transplant – Update and review of some current issues

“…More recent experience suggests no difference in graft survival between transfused and non-transfused organ recipients. 8 Table 1 e US organ transplants, waiting lists and adult three year graft and patient survival rates. …”

Untitled

“…1,2 Blood transfusions, previous transplants, and pregnancy-induced alloimmunization; thus, this sensitization leads to an increase in the incidence of acute rejection. It is well-known that waiting time for sensitized patients is longer than it is for who are not sensitized; therefore, graft survival was affected negatively because of the prolonged dialysis treatment.…”